SCHEMBL26962012

SCHEMBL26962012

CC(C)(C)OC(=O)N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(C4(F)CCC[N+](C)([O-])C4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26962164 0.88 PDK2 (0.33) PDK2
SCHEMBL26961932 0.83 NPY1R (0.32) PDK2
SCHEMBL26961807 0.80 SMN1; SMN2 (0.34) PDK2
SCHEMBL26961929 0.80 PDK2 (0.34) PDK2
SCHEMBL26961787 0.79 XIAP (0.32) —
SCHEMBL26961749 0.79 AKT1 (0.33) —
SCHEMBL26961717 0.79 HDAC6 (0.34) —
SCHEMBL26961880 0.79 KCNN4 (0.33) PDK2
SCHEMBL26961829 0.79 XIAP (0.32) —
SCHEMBL31628294 0.78 P2RY14 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 — — EP disclosed
Send feedback